06/04/2025
4:09 PM | GLAZER CAPITAL, LLC (Filed by)
Inozyme Pharma (Subject)
| Form SCHEDULE 13G | |
06/04/2025
3:51 PM | Inozyme Pharma (Subject)
| Form SC 14D9/A | |
06/04/2025
3:32 PM | BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
| Form SC TO-T/A | |
06/02/2025
6:35 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
6:14 AM | Inozyme Pharma (Subject)
| Form SC 14D9 | |
06/02/2025
5:25 AM | BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
| Form SC TO-T | |
05/30/2025
4:24 PM | Affinity Asset Advisors, LLC (Filed by)
Inozyme Pharma (Subject)
| Form SCHEDULE 13G/A | |
05/19/2025
8:23 PM | Inozyme Pharma (Subject)
| Form SC14D9C | |
05/19/2025
4:22 PM | BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
| Form SC TO-C | |
05/16/2025
8:44 PM | BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
| Form SC TO-C | |
05/16/2025
4:16 PM | BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
| Form SC TO-C | |
Get the Latest News and Ratings for INZY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter. |
05/16/2025
3:40 PM | Inozyme Pharma (Subject)
| Form SC14D9C | |
05/16/2025
7:06 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:33 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:36 AM | Inozyme Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
9:28 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Inozyme Pharma (Subject)
| Form SCHEDULE 13G/A | |
04/03/2025
3:27 PM | Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
3:27 PM | Inozyme Pharma (Issuer)
Subramanian Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
3:29 PM | Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:24 PM | Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:25 PM | Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:26 PM | Inozyme Pharma (Issuer)
Subramanian Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:17 PM | Inozyme Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/10/2025
7:31 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
7:31 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
7:32 AM | Inozyme Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/10/2025
7:32 AM | Inozyme Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
12:59 PM | Inozyme Pharma (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/10/2025
7:06 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
11:19 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Inozyme Pharma (Subject)
| Form SC 13G/A | |
11/05/2024
7:33 AM | Inozyme Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
7:31 AM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:34 PM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Inozyme Pharma (Subject)
| Form SC 13G | |
10/03/2024
7:58 PM | Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:57 PM | Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:52 PM | Inozyme Pharma (Filer)
| Form 424B5 | |
08/06/2024
3:54 PM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:30 PM | Inozyme Pharma (Issuer)
Mathers Edward T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:15 PM | Hopfner Robert Lorne (Reporting)
Inozyme Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:20 PM | Inozyme Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Gold Hits New Highs as Global Markets Spiral (Ad) When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839.
Now… as new tariffs take effect, gold is breaking records again.
You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER. Go Here to Learn What's Happening and How to Prepare >> |
Buy INZY Stock Free INZY Stock Alerts